// App-Quantinova.ai

1426 : Evaluation Of Sphingosine Kinase 1 As a Therapeutic Target In B-Lineage Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Craig T Wallington-Beddoe

Principal Investigators

  • Stuart M Pitson

  • Jason A Powell

  • Kenneth F Bradstock

  • Linda J Bendall

Medical Centers

  • Centre for Cancer Biology, SA Pathology, Adelaide, Australia

  • Department of Haematology, Westmead Hospital, Westmead, Australia

Locations

  • Australia

Companies

  • Millennium Pharmaceu

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • 1A/1B-light chain 3

  • B-cell lymphoma 2

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Cluster of Differentiation 34

  • Sphingosine-1-phosphate

Drug/Treatment

  • Vincristine

  • Doxorubicin

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved